BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31804681)

  • 1. Association between apurinic/apyrimidinic endonuclease 1 rs1760944 T>G polymorphism and susceptibility of cancer: a meta-analysis involving 21764 subjects.
    Ding G; Chen Y; Pan H; Qiu H; Tang W; Chen S
    Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31804681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between apurinic endonuclease 1 Asp148Glu polymorphism and gastrointestinal cancer risk: An updated meta-analysis.
    Dai ZJ; Shao YP; Kang HF; Tang W; Xu D; Zhao Y; Liu D; Wang M; Yang PT; Wang XJ
    World J Gastroenterol; 2015 Apr; 21(16):5081-9. PubMed ID: 25945024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between APE1 Single Nucleotide Polymorphism (rs1760944) and Cancer Risk: a Meta-Analysis Based on 6,419 Cancer Cases and 6,781 Case-free Controls.
    Dai ZJ; Wang XJ; Kang AJ; Ma XB; Min WL; Lin S; Zhao Y; Yang PT; Wang M; Kang HF
    J Cancer; 2014; 5(3):253-9. PubMed ID: 24665350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between APE1 rs1760944 and rs1130409 polymorphism with prostate cancer risk: A systematic review and meta-analysis.
    Liu J; Zheng J; Guo Y; Sheng X; Yin Y; Qian S; Xu B; Xiong W; Yin X
    Medicine (Baltimore); 2021 Nov; 100(46):e27630. PubMed ID: 34797286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of APE1 -656T > G and 1349 T > G polymorphisms and cancer risk: a meta-analysis based on 37 case-control studies.
    Zhou B; Shan H; Su Y; Xia K; Shao X; Mao W; Shao Q
    BMC Cancer; 2011 Dec; 11():521. PubMed ID: 22176746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between APE1 T1349G polymorphism and prostate cancer risk: evidence from a meta-analysis.
    Li X; Zhang G; Huai YJ; Cao ZQ
    Tumour Biol; 2014 Oct; 35(10):10111-9. PubMed ID: 25023401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between the APE1 Asp148Glu polymorphism and prostate cancer susceptibility: a meta-analysis based on case-control studies.
    Zhou X; Wei L; Jiao G; Gao W; Ying M; Wang N; Wang Y; Liu C
    Mol Genet Genomics; 2015 Feb; 290(1):281-8. PubMed ID: 25234162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apurinic/apyrimidinic endonuclease 1 polymorphisms are associated with ovarian cancer susceptibility in a Chinese population.
    Zhang X; Xin X; Zhang J; Li J; Chen B; Zou W
    Int J Gynecol Cancer; 2013 Oct; 23(8):1393-9. PubMed ID: 24257553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between APE1 ASP148GLU and colorectal cancer risk: A meta-analysis.
    Lin C; Jin Y; Cheng S; Wang W
    Clin Invest Med; 2020 Dec; 43(4):E24-34. PubMed ID: 33370522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. rs1760944 Polymorphism in the APE1 Region is Associated with Risk and Prognosis of Osteosarcoma in the Chinese Han Population.
    Xiao X; Yang Y; Ren Y; Zou D; Zhang K; Wu Y
    Sci Rep; 2017 Aug; 7(1):9331. PubMed ID: 28839218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APE1 Asp148Glu gene polymorphism and bladder cancer risk: a meta-analysis.
    Liu C; Yin Q; Li L; Zhuang YZ; Zu X; Wang Y
    Mol Biol Rep; 2013 Jan; 40(1):171-6. PubMed ID: 23143180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The APE1 Asp148Glu polymorphism and colorectal cancer susceptibility: a meta-analysis.
    Shen E; Liu C; Wei L; Hu J; Weng J; Yin Q; Wang Y
    Tumour Biol; 2014 Mar; 35(3):2529-35. PubMed ID: 24254302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between the APE1 Asp148Glu polymorphism and breast cancer susceptibility: a meta-analysis based on case-control studies.
    Zhao Z; Liu C; Zeng Y; Gu L; Ying M; Wang N; Hao B; Yao H; Su C; Wang Y; Ma Y
    Tumour Biol; 2014 May; 35(5):4727-34. PubMed ID: 24414702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DNA repair gene APE1 T1349G polymorphism and cancer risk: a meta-analysis of 27 case-control studies.
    Gu D; Wang M; Wang M; Zhang Z; Chen J
    Mutagenesis; 2009 Nov; 24(6):507-12. PubMed ID: 19762350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APE1 Asp148Glu gene polymorphism and lung cancer risk: a meta-analysis.
    Ji YN; Zhan P; Wang J; Qiu LX; Yu LK
    Mol Biol Rep; 2011 Oct; 38(7):4537-43. PubMed ID: 21132382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APE1 Asp148Glu polymorphism and lung cancer susceptibility.
    Cai L; Fu Y; Zhang Y
    Tumour Biol; 2014 Jun; 35(6):5237-44. PubMed ID: 24523018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A genetic variant in the APE1/Ref-1 gene promoter -141T/G may modulate risk of glioblastoma in a Chinese Han population.
    Zhou K; Hu D; Lu J; Fan W; Liu H; Chen H; Chen G; Wei Q; Du G; Mao Y; Lu D; Zhou L
    BMC Cancer; 2011 Mar; 11():104. PubMed ID: 21429202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Polymorphisms in DNA Repair Gene APE1/Ref-1 and the Risk of Neural Tube Defects in a High-Risk Area of China.
    Wang X; Yue H; Li S; Guo J; Guan Z; Zhu Z; Niu B; Zhang T; Wang J
    Reprod Sci; 2021 Sep; 28(9):2592-2601. PubMed ID: 33761125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genetic variant in the promoter of APE1 gene (-656 T>G) is associated with breast cancer risk and progression in a Chinese population.
    Kang H; Dai Z; Ma X; Ma L; Jin Y; Liu X; Wang X
    Gene; 2013 Nov; 531(1):97-100. PubMed ID: 23994194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of a promoter polymorphism in APE1/Ref-1 that contributes to reduced lung cancer susceptibility.
    Lu J; Zhang S; Chen D; Wang H; Wu W; Wang X; Lei Y; Wang J; Qian J; Fan W; Hu Z; Jin L; Shen H; Huang W; Wei Q; Lu D
    FASEB J; 2009 Oct; 23(10):3459-69. PubMed ID: 19541747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.